Evidence map›Paper›PMID 41149833›Full record

ArticleJournal of personalized medicine2025

Comorbidities as a Personalized Target in Patients with Severe Asthma Treated with Dupilumab.

Carlota Gonzalez-Lluch, Maria Basagaña, Laura Pardo, Paula Cruz Toro, Agnes Hernandez-Biette, Carlos Martinez-Rivera, Ignasi Garcia-Olive

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of personalized medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Switching to dupilumab from other biologic therapies in chronic rhinosinusitis with nasal polyps (CRSWNP): a comparison with biologic-naïve patients.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Carlota Gonzalez-LluchDepartment of Ear, Nose and Throat, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain.
Maria BasagañaDepartment of Allergology, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain.
Laura PardoDepartment of Ear, Nose and Throat, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain.
Paula Cruz ToroDepartment of Ear, Nose and Throat, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain.
Agnes Hernandez-BietteDepartment of Respiratory Medicine, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain.
Carlos Martinez-RiveraDepartment of Respiratory Medicine, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain.ORCID 0000-0003-1031-2561
Ignasi Garcia-OliveDepartment of Respiratory Medicine, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

asthmacomorbiditiesdupilumabpersonalized medicinereal-life study

Identifiers

PMID41149833
PMCPMC12565378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.